Literature DB >> 11744231

Group 2 metabotropic glutamate receptors induced long term depression in mouse striatal slices.

L Kahn1, G Alonso, D Robbe, J Bockaert, O J Manzoni.   

Abstract

We studied the roles of mGlu2/3 receptors (mGlu2/3) in glutamatergic transmission at corticostriatal synapses in mice brain slices. Perfusion of the selective mGlu2/3 agonists LY354740 and L-CCG1 caused the long term depression (LTD) of evoked synaptic responses. Photonic and electronic microscopy showed mGlu2/3 on axonal fibers and glial processes but not on striatal dendrites. mGlu2/3-LTD was independent of synaptic activity and insensitive to specific antagonists of dopamine D1, D2, GABA(B), N-methyl-D-aspartate or adenosine A1 receptors. Manipulation of the cAMP/protein kinase A cascade had no effect on the mGlu2/3-LTD. In contrast, MEK1-2 inhibitors reduced both mGlu2/3 initial depression and LTD suggesting the involvement of the mitogen activated kinase pathway in mGlu2/3-LTD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744231     DOI: 10.1016/s0304-3940(01)02397-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3.

Authors:  Marc Flajolet; Sergey Rakhilin; Hong Wang; Natalia Starkova; Nina Nuangchamnong; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

2.  Synapses between parallel fibres and stellate cells express long-term changes in synaptic efficacy in rat cerebellum.

Authors:  Armelle Rancillac; Francis Crépel
Journal:  J Physiol       Date:  2003-11-14       Impact factor: 5.182

3.  Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata.

Authors:  Kari A Johnson; Colleen M Niswender; P Jeffrey Conn; Zixiu Xiang
Journal:  Neurosci Lett       Date:  2011-09-16       Impact factor: 3.046

Review 4.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

5.  Age-dependent impairment of metabotropic glutamate receptor 2-dependent long-term depression in the mouse striatum by chronic ethanol exposure.

Authors:  Kari A Johnson; Daniel J Liput; Gregg E Homanics; David M Lovinger
Journal:  Alcohol       Date:  2019-06-21       Impact factor: 2.405

6.  Activation of synaptic group II metabotropic glutamate receptors induces long-term depression at GABAergic synapses in CNS neurons.

Authors:  Zheng-Quan Tang; Yu-Wei Liu; Wei Shi; Emilie Hoang Dinh; William R Hamlet; Rebecca J Curry; Yong Lu
Journal:  J Neurosci       Date:  2013-10-02       Impact factor: 6.167

7.  Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).

Authors:  Michael P Johnson; David Barda; Thomas C Britton; Renee Emkey; William J Hornback; G Erik Jagdmann; David L McKinzie; Eric S Nisenbaum; Joseph P Tizzano; Darryle D Schoepp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

8.  Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum.

Authors:  Kari A Johnson; Yolanda Mateo; David M Lovinger
Journal:  Neuropharmacology       Date:  2017-01-31       Impact factor: 5.250

9.  Inhibition of presynaptic calcium transients in cortical inputs to the dorsolateral striatum by metabotropic GABA(B) and mGlu2/3 receptors.

Authors:  David A Kupferschmidt; David M Lovinger
Journal:  J Physiol       Date:  2015-04-13       Impact factor: 5.182

Review 10.  Alcohol and basal ganglia circuitry: Animal models.

Authors:  David M Lovinger; Veronica A Alvarez
Journal:  Neuropharmacology       Date:  2017-03-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.